Researchers from SUNY Downstate’s College of Medicine and the School of Public Health are participating in the study. The study is being developed in conjunction with the National Stroke Association and the Arthur Ashe Institute for Urban Health. The grant team will survey stroke survivors and their caregivers to investigate the interest in and preference for smart phone apps to improve identifying and managing risk factors. For more information, go to http://www.pcori.org/.
Dr. Levine is also the principal investigator on SUNY’s Downstate’s NIH-funded clinical trial network referred to as the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) involving four SUNY medical center campuses.
The Network was created to conduct studies for treatments for neurological diseases through partnerships with academia, private foundations, and industry. The network is designed to expand the National Institute of Neurological Disorders and Stroke’s (NINDS) capability to test promising new therapies. The plan is to increase the efficiency of clinical trials before embarking on larger studies in order to respond quickly as new opportunities arise. The network includes multiple clinical sites, a Clinical Coordinating Center and one Data Coordinating Center. For more information, go to http://www.neuronext.org/.
On June 4, 2012, NINDS released a notice for a webinar to be held August 2, 2012 at 1:00 PM to introduce new academic investigators and existing Neurological Disease Study Groups to the NeuroNEXT network. An overview of the network will be given including the scope, purpose, and available resources. To sign up, go to https://www1.gotomeeting.com/register/306886344.
